Fast-track your progress with our leading-edge technology and deep expertise in viral vector and
nucleic acid services
![Univercells parent company Exothera SA is a Univercells company](https://exothera.world/wp-content/uploads/2023/09/UNVC_mention_white_horizontal_2.png)
Full-service Contract Development and Manufacturing Organization
Exothera is a specialized CDMO delivering pre-clinical to commercial GMP manufacturing services for viral vector and RNA therapeutics and vaccines.
As a Univercells company, Exothera capitalizes on novel manufacturing technologies invented in-house and unparalleled bioprocessing expertise to help you impact patient lives.
![Platform-manufacturing- technology.jpg Viral Vector-based therapeutics development and manufacturing process GMP Platform](https://exothera.world/wp-content/uploads/2023/09/HOMEPAGE_1_V2-1.webp)
Full-service Contract Development and Manufacturing Organization
Exothera is a specialized CDMO delivering pre-clinical to commercial GMP manufacturing services for viral vector and RNA therapeutics and vaccines.
As a Univercells company, Exothera capitalizes on novel manufacturing technologies invented in-house and unparalleled bioprocessing expertise to help you impact patient lives.
![Platform-manufacturing- technology.jpg Viral Vector-based therapeutics development and manufacturing process GMP Platform](https://exothera.world/wp-content/uploads/2023/09/HOMEPAGE_1_mobile.webp)
Our Services
Viral vectors
Experience industry leading titers for AAV and AV while leveraging deep expertise in fixed bed and stirred tank processes from the inventors of the iCellis and Scale-X bioreactors.
Learn more about our experience with AAV, AV, VLP, MVA, LVV, baculovirus
and other viral vectors.
![viral-vectors-process-design-development.png](https://exothera.world/wp-content/uploads/2023/01/Services_hexagons_2023_OK.png)
Nucleic acids
Achieve higher yields at consistently higher quality by harnessing NtensifyTM technology by Quantoom Biosciences.
By integrating our solutions into your evolution, we help you sidestep common process development and scale up hurdles to smooth the journey from concept to market.
![nucleic-acids-process-design-development.png](https://exothera.world/wp-content/uploads/2023/06/Main-process-flow-short-.png)
Our Services
Viral vectors
Experience industry leading titers for AAV and AV while leveraging deep expertise in fixed bed and stirred tank processes from the inventors of the iCellis and Scale-X bioreactors.
Learn more about our experience with AAV, AV, VLP, MVA, LVV, baculovirus and other viral vectors.
![viral-vectors-process-design-development.png](https://exothera.world/wp-content/uploads/2023/01/Services_hexagons_2023_OK.png)
Nucleic acids
Achieve higher yields at consistently higher quality by harnessing NtensifyTM technology by Quantoom Biosciences.
By integrating our solutions into your evolution, we help you sidestep common process development and scale up hurdles to smooth the journey from concept to market.
![nucleic-acids-process-design-development.png](https://exothera.world/wp-content/uploads/2023/06/Main-process-flow-short-.png)
What our customers think about our services
92,548
(8,600)
square feet (square meters)
of facility space
+170
employees
up to 3,229
(600)
square feet (square meters) fixed bed
up to 2,000
liters scale stirred tanks
Our Facilities
Exothera is located in Belgium, south of Brussels in Charleroi as well as Andover, Massachusetts in the US.
Our Facilities
Exothera is located in Belgium, south of Brussels in Charleroi as well as
Andover, Massachusetts in the US.
![Viral vector scalability up to 600 m² / 6458 ft² (adherent) and 2000 L (suspension) State-of-the-art Facility and the Best Customer Experience to serve you and your patients](https://exothera.world/wp-content/uploads/2023/09/BETA-VISUALS_Univercells-image-B-mid-size-web-scaled.jpg)
From discovery to GMP, our ecosystem of solutions is designed to
support you at every stage.
Our Differentiators
Game-changing technologies
Developed in-house, our innovative viral vector and nucleic acid technologies offer world-first capabilities that can dramatically cut costs and timelines, without compromising quality.
Exceptional customer experience — 100% customer satisfaction
Our unwavering commitment to customer satisfaction is reflected in our outstanding customer survey scores. Our experienced team and attentive service mean you’re in safe hands.
Unrivaled capabilities from clinical to commercial
From discovery to GMP, our ecosystem of solutions is designed to support you at every stage. Our expertise in process development and scale-up ensures that you achieve the highest titers and the highest quality product on your journey to successful drug development and commercialization.
Our Differentiators
Game-changing technologies
Developed in-house, our innovative viral vector and nucleic acid technologies offer world-first capabilities that can dramatically cut costs and timelines, without compromising quality.
Exceptional customer experience — 100% customer satisfaction
Our unwavering commitment to customer satisfaction is reflected in our outstanding customer survey scores. Our experienced team and attentive service mean you’re in safe hands.
Unrivaled capabilities from clinical to commercial
From discovery to GMP, our ecosystem of solutions is designed to support you at every stage. Our expertise in process development and scale-up ensures that you achieve the highest titers and the highest quality product on your journey to successful drug development and commercialization.
Trusted by
![Best CDMO partner for viral vector and nucleic acids manufacturing Exothera is unique in the CDMO industry with a 100% customer satisfaction for 3 years in a row](https://exothera.world/wp-content/uploads/2023/08/montage_logos_8_Alexion_without-Val_without-Reithera.png)